Rohith Haliyur Shivanna | Microbiology | Best Researcher Award

Dr. Rohith Haliyur Shivanna | Microbiology | Best Researcher Award

Icahn School of Medicine at Mount Sinai | United States

Dr. Rohith H. Shivanna is a dedicated biotechnologist and microbiologist with over nine years of research experience and one year of industry exposure. Currently serving as a Post-Doctoral Fellow in the Department of Genetics and Genomic Sciences at the Icahn School of Medicine at Mount Sinai, New York, USA, Dr. Shivanna has extensive expertise in molecular microbiology, food product development, and probiotics.

Professional profileπŸ‘€

Google Scholar

Strengths for the Awards✨

  • Extensive Research Experience: Nine years of diverse research across molecular microbiology, fermentation technology, probiotics, and genetics.
  • Interdisciplinary Expertise: Combines knowledge in microbiology, biotechnology, food product development, genetics, and genomic sciences.
  • Practical Skills: Mastery in molecular biology, fermentation, product development, and advanced techniques like ATAC-sequencing and chromatin remodeling.
  • Publication and Conference Contributions: Presented at multiple prestigious conferences, highlighting his active engagement with the scientific community.
  • Leadership and Collaboration: Worked under esteemed mentors and contributed to numerous projects, showcasing collaboration and leadership abilities.
  • Global Research Exposure: Current post-doctoral role at the Icahn School of Medicine at Mount Sinai, New York, demonstrates global recognition and engagement.

πŸŽ“ Education

  • Ph.D. in Biotechnology (2017-2022, awarded in 2023) – CSIR-CFTRI, Mysuru, Mangalore University, India.
  • M.Sc. in Biotechnology (2010-2012) – University of Mysore, India (7.3 CGPA).
  • B.Sc. in Biochemistry, Microbiology, and Biotechnology (2007-2010) – University of Mysore, India (63.10%).

πŸ’Ό Experience

  • Post-Doctoral Fellow (May 2023 – Present) – Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, USA.
  • Project/Technical Assistant (June 2022 – May 2023) – NPIC-CIF Dept., CSIR-CFTRI, Mysore, India.
  • Ph.D. Researcher (May 2017 – June 2022) – Microbiology and Fermentation Department, CSIR-CFTRI, Mysore, India.
  • Project Assistant (May 2015 – March 2017) – CSIR-CFTRI, Mysore, India.
  • Clinical Process Associate-2 (October 2014 – April 2015) – Quintiles Research Pvt. Ltd., Bangalore, India.
  • Project Assistant (August 2013 – September 2014) – Food Microbiology Department, CSIR-CFTRI, Mysore, India.
  • R&D Trainee (February 2013 – July 2013) – Bacardi India Pvt. Ltd., Nanjangud, Mysore, India.

πŸ”¬ Research Interests On Microbiology

Dr. Shivanna’s research focuses on probiotics, microbiology, fermentation technology, immune modulation, food product development, genetic studies, chromatin remodeling, and molecular mechanisms of inflammatory diseases.

πŸ† Awards

  • ICMR-SRF Fellowship – Awarded during Ph.D. research.
  • Recognition for Poster Presentation at multiple conferences, including the Probiotics Association of India and International Symposium on Probiotics & Immunity.

πŸ“š Publications

  • Title: The Combined Effect of Potential Probiotic Bacillus licheniformis MCC 2514 and Bifidobacterium breve NCIM 5671 Towards Anti-inflammatory Activity on HT-29
    Authors: R. H. S., P. M. Halami
    Year: 2021
    Citations: 24

  • Title: In vitro validation studies for adhesion factor and adhesion efficiency of probiotic Bacillus licheniformis MCC 2514 and Bifidobacterium breve NCIM 5671 on HT-29
    Authors: H. S. Rohith, P. M. Halami
    Year: 2021
    Citations: 22

  • Title: Probiotic Bacillus licheniformis MCC2514 and Bifidobacterium breve NCIM 5671 Regulates GATA3 and Foxp3 Expression in the Elevated Disease Condition
    Authors: H. S. Rohith, M. S. Peddha, P. M. Halami
    Year: 2024
    Citations: 5

  • Title: Efficacy of probiotic bacteria in alleviating T helper cell-associated immune response
    Authors: H. S. Rohith
    Year: 2022

  • Title: In Vitro Validation Studies For Adhesion Factor and Adhesion Efficiency of Probiotic Bacillus licheniformis MCC 2514 and Bifidobacterium breve NCIM 5671 on HT-29 Cell Lines
    Authors: R. H. S., P. M. Halami
    Year: 2021

  • Title: Aqueous two phase system for downstream processing of proteins
    Authors: A. S. Bhandiwad, B. S. Karanth, H. S. Rohith, T. B. S. Gowda
    Year: 2002

πŸ” Conclusion

Dr. Rohith H. Shivanna’s journey in biotechnology and microbiology reflects a strong commitment to advancing scientific knowledge and developing practical applications for health and nutrition. His diverse research interests, practical skills, and international experience position him as a rising expert in the field, contributing significantly to both academia and industry.

Yun zou | Microbiology | Best Researcher Award

Mr. Yun zou | Microbiology | Best Researcher Award

The General Hospital of Western Theater Command | China

Zou Xinyun is a Master’s degree candidate and Chief Technician with a strong background in oncology and biomedical engineering. Since graduating from Hubei University of Science and Technology in 2011, he has been dedicated to medical research and clinical practice at the General Hospital of the Western Theater Command of the Chinese People’s Liberation Army. Currently, he is pursuing his Master’s degree in Biomedical Engineering at the School of Medicine, Southwest Jiaotong University, under the guidance of Professor Zhang Ling. His research contributions have been recognized through multiple prestigious awards and numerous scientific publications.

ProfileπŸ‘€

ORCID

Strengths for the Awards✨

  • Extensive Research Contributions πŸ“š

    • Zou Xinyun has published five SCI papers as the first author in reputable journals, including Translational Cancer Research, Discover Oncology, and Clinical and Experimental Hypertension.
    • He has also co-authored several other publications, demonstrating his active involvement in collaborative research.
  • Academic Excellence & Recognition πŸŽ“

    • He is a National Graduate Scholarship recipient, which highlights his academic excellence and dedication to research.
    • Recognized as an Outstanding Graduate of Hubei University of Science and Technology and an Excellent Medical Worker at his hospital, indicating his exceptional contributions to both research and clinical practice.
  • Strong Clinical and Research Background πŸ₯

    • With over a decade of experience at the Department of Oncology in a leading military hospital, he has gained deep expertise in clinical oncology research.
    • His ongoing Master’s in Biomedical Engineering at Southwest Jiaotong University under Professor Zhang Ling demonstrates a strong interdisciplinary approach to cancer research.
  • Zou Xinyun has an impressive research profile, particularly in oncology and biomedical engineering, with multiple SCI-indexed publications, academic excellence awards, and clinical research experience. While he is a strong candidate for the Best Researcher Award, focusing on high-impact publications, independent funding, and broader collaborations could further solidify his position as a top-tier researcher in his field.

πŸŽ“ Education

  • Bachelor’s Degree (2011) – Hubei University of Science and Technology
  • Master’s Degree Candidate (2021–2024) – School of Medicine, Southwest Jiaotong University
    • Research supervised by Professor Zhang Ling
    • Specializing in Biomedical Engineering

πŸ₯ Experience

  • 2011–Present: Chief Technician, Department of Oncology, General Hospital of the Western Theater Command, Chinese People’s Liberation Army
    • Over a decade of experience in oncology research and clinical applications
    • Involved in advanced medical diagnostics and cancer treatment strategies

πŸ”¬ Research Interests On Microbiology

Zou Xinyun’s research focuses on oncology, biomedical engineering, and clinical cancer treatment. His work explores innovative approaches in cancer diagnostics, therapeutic interventions, and biomedical applications to improve patient outcomes. He is particularly interested in translational cancer research and the development of novel treatment methodologies.

πŸ† Awards & Honors

  • πŸ… Outstanding Graduate – Hubei University of Science and Technology
  • πŸ… Excellent Medical Worker – General Hospital of the Western Theater Command
  • πŸ… National Graduate Scholarship – Recognized for academic excellence and research contributions

πŸ“š Publications

  • Title: Association between immune cells and endometrial cancer: A bidirectional Mendelian randomization study

    • Authors: Xinyun Zou, Jinlan Shen, Hengdi Zhang, Fangyuan Kong, Xuemei Jin, Ling Zhang
    • Year: 2024
    • Citations: Not provided
  • Title: The causal effects of immune cells on pancreatic cancer: A 2‑sample Mendelian randomization study

    • Authors: Zou X, Shen J, Yong X, Diao Y, Ling Zhang
    • Year: 2024
    • Citations: Not provided
  • Title: Emodin ameliorates myocardial fibrosis in mice by inactivating the ROS/PI3K/Akt/mTOR axis

    • Authors: Huang W, Zhou P, Zou X, Liu Y, Zhou L, Zhang Y
    • Year: 2024
    • Citations: Not provided
  • Title: Radiomics in Nasopharyngeal Carcinoma

    • Authors: Wenyue Duan, Xiong B, Tian T, Zou X, He Z, Ling Zhang
    • Year: 2022
    • Citations: Not provided

πŸ”š Conclusion

Zou Xinyun is a dedicated researcher and medical professional with a strong commitment to oncology and biomedical engineering. His contributions to cancer research, coupled with his clinical expertise, have earned him significant recognition in the medical field. With a solid track record of academic excellence, professional experience, and impactful publications, he continues to advance medical science and improve patient care.

Lina Fan | Microbiology | Best Researcher Award

Dr. Lina Fan | Microbiology | Best Researcher Award

Distinguished researcher | The Second Affiliated Hospital of Zhejiang University School of Medicine | China

Lina Fan is a distinguished researcher and physician, specializing in gut microbiota, immune microenvironment, and colorectal tumorigenesis. She obtained her Ph.D. from Zhejiang University and currently works as a gastroenterologist at the Second Affiliated Hospital of Zhejiang University School of Medicine. Her work focuses on the intricate relationship between gut microbiota and cancer, contributing significantly to the field with several impactful publications.

Profile

Scopus

Strengths for the Awards

  • Strong Academic Background:
    • Lina holds a Ph.D. from Zhejiang University, a prestigious institution, and works as a distinguished researcher and physician.
  • Research Focus:
    • Her research is centered on the highly impactful areas of gut microbiota, immune microenvironment, and colorectal cancer, all of which have significant implications for medical science.
  • High-Quality Contributions:
    • She has contributed significantly to the understanding of gut microbiota’s relationship with colorectal cancer and immune microenvironments, evidenced by the completion of substantial research on Bifidobacterium adolescentis and other microbiota in colorectal cancer.
  • Publications and Editorial Appointments:
    • Although there is no explicit mention of indexed journal publications, Lina holds editorial positions in well-regarded journals such as Cancer Immunology Research, Gut Microbes, and Cancer Communications, showcasing recognition from the research community.

Education πŸŽ“

Lina Fan earned her Ph.D. from Zhejiang University, where she honed her expertise in gastrointestinal research. As a researcher and physician, she has contributed to advancements in understanding the immune microenvironment and gut microbiota’s role in colorectal cancer, laying the foundation for her future work.

Experience πŸ₯

Lina has served as a gastroenterologist and researcher at the Second Affiliated Hospital of Zhejiang University School of Medicine. She has been actively involved in studies examining the gut microbiota, immune system, and their relationship to digestive cancers, particularly colorectal cancer, producing multiple high-impact research articles in the process.

Research Interests On MicrobiologyπŸ”¬

Her research interests center on gut microbiota, the immune microenvironment, and their roles in colorectal tumorigenesis. Specifically, Lina has worked on understanding how specific microbes, like Bifidobacterium adolescentis, influence cancer development. Her ongoing projects explore the effects of gut microbiota on metabolic syndrome and the immune response in cancer.

Awards πŸ†

Lina has been nominated for prestigious awards, including the Young Scientist Award and the Best Researcher Award, recognizing her groundbreaking work in cancer immunology and microbiome research. Her research has been recognized both nationally and internationally for its innovation and contributions to the scientific community.

Publications πŸ“°

  • Lactobacillus intestinalis facilitates tumor-derived CCL5 to recruit dendritic cell and suppress colorectal tumorigenesis
    • Authors: Sun, Y., Wang, Q., Jiang, Y., Chen, S., Fan, L.
    • Year: 2025
    • Citations: 0
  • Microbial metabolite enhances immunotherapy efficacy by modulating T cell stemness in pan-cancer
    • Authors: Jia, D., Wang, Q., Qi, Y., Chen, S., Wang, L.
    • Year: 2024
    • Citations: 47
  • Correction: Bifidobacterium adolescentis induces Decorin+ macrophages via TLR2 to suppress colorectal carcinogenesis
    • Authors: Lin, Y., Fan, L., Qi, Y., Chen, S., Wang, L.
    • Year: 2023
    • Citations: 0
  • Bifidobacterium adolescentis induces Decorin+ macrophages via TLR2 to suppress colorectal carcinogenesis
    • Authors: Lin, Y., Fan, L., Qi, Y., Chen, S., Wang, L.
    • Year: 2023
    • Citations: 19
  • Bifidobacterium adolescentis orchestrates CD143+ cancer-associated fibroblasts to suppress colorectal tumorigenesis by Wnt signaling-regulated GAS1
    • Authors: Chen, S., Fan, L., Lin, Y., Si, J., Wang, L.
    • Year: 2023
    • Citations: 14
  • Lactobacillus johnsonii alleviates colitis by TLR1/2-STAT3 mediated CD206+ macrophagesIL-10 activation
    • Authors: Jia, D.-J.-C., Wang, Q.-W., Hu, Y.-Y., Chen, S.-J., Wang, L.-J.
    • Year: 2022
    • Citations: 70
  • Akkermansia muciniphila Alleviates Dextran Sulfate Sodium (DSS)-induced acute colitis by NLRP3 activation
    • Authors: Qu, S., Fan, L., Qi, Y., Liu, W., Si, J.
    • Year: 2021
    • Citations: 153
  • Akkermansia muciniphila suppresses colorectal tumorigenesis by inducing TLR2/NLRP3-mediated M1-like TAMs
    • Authors: Fan, L., Xu, C., Ge, Q., Chen, S., Wang, L.
    • Year: 2021
    • Citations: 94
  • Fusobacterium nucleatum promotes colorectal cancer metastasis through miR-1322/CCL20 axis and M2 polarization
    • Authors: Xu, C., Fan, L., Lin, Y., Si, J., Chen, S.
    • Year: 2021
    • Citations: 146
  • Bifidobacterium adolescentis ameliorates chronic colitis by regulating Treg/Th2 response and gut microbiota remodeling
    • Authors: Fan, L., Qi, Y., Qu, S., Si, J., Chen, S.
    • Year: 2021
    • Citations: 141

Conclusion

Dr. Lina Fan’s research has made significant strides in exploring the complex relationship between gut microbiota and colorectal cancer. Her work continues to shape the field, with groundbreaking findings that may lead to novel therapeutic strategies. With her commitment to advancing medical knowledge, she is undoubtedly a key figure in the scientific community.